GNC To Pay $2.25 Million To Avoid Misbranded Stimulant Charges

GNC To Pay $2.25 Million To Avoid Misbranded Stimulant Charges

GNC Holdings Inc. has agreed to pay $2.25 million to the U.S. government as part of a non-prosecution agreement announced by the  U.S. Department of Justice. GNC sold a misbranded supplement produced by USPLabs LLC in 2013. GNC sold the product based on representations from USP Labs that ingredients contained in the product complied with the law, but did not undertake additional testing or otherwise verify that the ingredients in the product were as represented. USP Labs was indicted in November 2015, and charged with importing synthetic stimulants from China using false certificates of analysis and false labeling, and claiming that the  synthetic stimulants were natural plant derivatives. [12/8/16]

Search